Combination therapy of antiretroviral drugs together with IFNα14 further reduced the viral loads in chronically HIV-infected humanized mice (12), suggesting that IFN therapy with the right subtype (increased antiviral and immunomodulatory activity, reduced side effects) might still be an option to treat HIV infection. Here, IFNA14 is linked to HIV infectious disease.